Autolus Therapeutics plc - ADR
AUTL
Get informed when a big investor buys or sells
+ FollowMarket Cap$493.7M
Close$
$-1.15
162% downside
Current Fair Value
162% downsideOvervalued by 162% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $493.70 Million |
|---|---|
| Enterprise Value | $405.79 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.08 |
| Beta | 2.09 |
| Outstanding Shares | 266,158,829 |
Return
| Return on Equity | -374.17% |
|---|---|
| Return on Assets | -56.77% |
| Return on Invested Capital | -55.56% |
Valuation & Multiples
| P/E Ratio | -1.75 |
|---|---|
| PEG | 9.52 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.46 |
| Enterprise Value to EBIT | -1.72 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 1.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$38.56 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$38.11 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 321,100▼ 5.20% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 49.67%▼ 0.84% |
|---|---|
| Total Invested | $211.97M▲ 14.98% |
| Investors Holding | 86▼ 1.00% |
ESG Score
No data